4//SEC Filing
MYERS GRIFFIN 4
Accession 0001209191-22-043567
CIK 0001564406other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 6:55 PM ET
Size
7.5 KB
Accession
0001209191-22-043567
Insider Transaction Report
Form 4
MYERS GRIFFIN
DirectorChief Medical Officer
Transactions
- Sale
Common Stock, $0.001 par value
2022-07-28$28.97/sh−32,556$943,278→ 5,054,159 total(indirect: By Trust) - Sale
Common Stock, $0.001 par value
2022-07-28$28.57/sh−167,444$4,783,373→ 5,086,715 total(indirect: By Trust)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F2]Transactions within a $1.00 price range are reported in accordance with the June 25th 2008 SEC No-Action letter. Minimum price was $27.92 and maximum price was $28.91.
- [F3]Transactions within a $1.00 price range are reported in accordance with the June 25th 2008 SEC No-Action letter. Minimum price was $28.92 and maximum price was $29.09.
Documents
Issuer
Oak Street Health, Inc.
CIK 0001564406
Entity typeother
Related Parties
1- filerCIK 0001793352
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 6:55 PM ET
- Size
- 7.5 KB